June 12, 2026 · Form 4 insider transaction
GRAMMER ELIZABETH A bought 39,567 shares of Sagimet Biosciences Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.